Subscribe To
Humacyte: major catalysts ahead, solid prospects, low prices
Humacyte develops regenerative human tissue for various medical uses, with upcoming BLAs and interest from the US military. Their core technology, Hum...
August 22, 2023, 3:28 am
Zyversa therapeutics reports second quarter 2023 corporate and financial results
Key Highlights: Advanced clinical development initiatives for Cholesterol Efflux Mediator™ VAR 200, with planned initiation of a ...
August 21, 2023, 8:15 pm
Wti oil technical: potential bullish reversal to resume medium-term uptrend
The recent decline of -6.8% from its 10 August 2023 high has not damaged the medium-term uptrend phase ...
August 21, 2023, 12:49 pm
Exelixis' (exel) prostate cancer study meets primary endpoint
Exelixis (EXEL) and partner Ipsen's phase III CONTACT-02 study meets one of the two primary endpoints i...
August 21, 2023, 12:47 pm
Bundesbank: germany economy to stagnate, inflation to stay above 2%
In its latest monthly report, Bundesbank paints a sobering picture of the German economy, which remains ensnared in a weak phase. Key factors hamperin...
August 21, 2023, 12:43 pm
Wti oil technical: potential bullish reversal to resume medium-term uptrend
The recent decline of -6.8% from its 10 August 2023 high has not damaged the medium-term uptrend phase ...
August 21, 2023, 12:06 pm
Tonix pharmaceuticals announces results of pre-ind meeting with fda for tnx-801 as a potential vaccine to prevent mpox and smallpox
phase 1/2 Clinical Trial of TNX-801 for the Prevention of Mpox and Smallpox to Commence Following Submi...
August 21, 2023, 11:00 am
Gilead sciences told by fda to pause patient enrollment in leukemia drug trials
Gilead Sciences, Inc. (NASDAQ:GILD) said the Food and Drug Administration (FDA) has put a clinical hold on its studies evaluating its investigation an...
August 21, 2023, 10:41 am
Uk's competition regulator clears broadcom's swoop for vmware
The UK Competition & Markets Authority has cleared Broadcom Inc's planned acquisition of VMware Inc, after an in-depth ...
August 21, 2023, 10:21 am
Eyepoint: well-funded and catalyst-rich, but not without risks
EyePoint Pharmaceuticals is developing the EYP-1901 treatment for wet age-related macular degeneration and non-proliferative diabetic retinopathy. Q2 ...
August 21, 2023, 8:31 am
Nanoviricides reports progress in phase 1a/1b human clinical trial of nv-cov-2 broad-spectrum antiviral drug
NanoViricides (NYSE-A:NNVC) has reported that the phase 1a/1b human clinical trial of its broad-spectru...
August 21, 2023, 8:16 am
U.k. competition authority provisionally clears broadcom, vmware merger
Following an “in-depth” phase 2 investigation, the U.K.'s Competition and Markets Authority (CMA) o...
August 21, 2023, 6:58 am
Aud/jpy technical: watch 92.80 key downside trigger level
Weak medium-term momentum may kickstart a medium-term downtrend phase for AUD/JPY. Key short-term resis...
August 21, 2023, 6:52 am
Aud/jpy technical: watch 92.80 key downside trigger level
Weak medium-term momentum may kickstart a medium-term downtrend phase for AUD/JPY. Key short-term resis...
August 21, 2023, 6:29 am
Usdjpy daily analysis – august 21, 2023
USDJPY appears to be staying within a rising price channel on the 4-hour chart, suggesting a potential uptrend from 138.05. As long as the channel sup...
August 21, 2023, 1:46 am
The 7 most undervalued entertainment stocks to buy now: august 2023
In the vibrant realm of media stocks, the quest for undervalued entertainment stocks has never been more enticing. The entertainment industry has show...
August 20, 2023, 11:09 am
Agnc: a hefty 15% yield against a chaotic post-pandemic zeitgeist
AGNC now yields 15% on the back of monthly cash dividends that have remained stable at $0.12 per share for the last three years. The mREIT's tangible ...
August 20, 2023, 7:39 am
3 reasons enphase stock, down 62%, is a buy now
Investors have turned away from a lot of solar stocks, including Enphase. Short-term cyclical challenges in the U.S. are masking international expansi...
August 20, 2023, 5:11 am
Metallic minerals going after klondike alluvial deposits
(Kitco News) - At La Plata, a discovery earlier this year prompted a $6.3 million investment from Newcrest Mining, which funded a first-...
August 18, 2023, 6:07 pm
Enliven therapeutics: preclinical company with interesting value proposition
Enliven Therapeutics, Inc. is a recently merged biopharma company focused on developing oncology candidates for leukemia and lymphoma. The company has...
August 18, 2023, 12:57 pm